The 66 references in paper I. TSYMBALYUK Y., A. MANUILOV M., K. POPOV A., F. KHUBIEVA U., E. GILEVA E., И. ЦЫМБАЛЮК Ю., А. МАНУЙЛОВ М., К. ПОПОВ А., Ф. ХУБИЕВА У., Е. ГИЛЕВА Э. (2017) “БИОЛОГИЧЕСКАЯ АКТИВНОСТЬ ДИХЛОРАЦЕТАТА НАТРИЯ: ЭФФЕКТИВНОСТЬ В ЭКСПЕРИМЕНТАЛЬНО-КЛИНИЧЕСКИХ ИССЛЕДОВАНИЯХ // THE BIOLOGICAL ACTIVITY OF SODIUM DICHLOROACETATE AND ITS EFFECTIVENESS DURING THE EXPERIMENTAL CLINICAL STUDIES” / spz:neicon:ksma:y:2017:i:2:p:151-162

1
Васляева С. Н., Люсов В. А., Цыганкова О. В., Гордеев И. Г., Волов Н. А. Безболевая ишемия миокарда: патогенетические и патофизиологические механизмы. Традиционные и метаболические аспекты терапии // Российский кардиологический журнал. – 2004. – No 4(48). – С. 74-83.
(check this in PDF content)
2
Мануйлов А. М., Попов К. А., Цымбалюк И. Ю., Литвинова М. Г., Хубиева Ф. У. Шестопалов А. В. Биологическая активность дихлорацетата натрия: концепции и механизмы (обзор литературы) // Кубанский научный медицинский вестник. – 2016. – No 6 (161). – С. 156–163.
(check this in PDF content)
3
Сорокіна Л., Бiлюк А., Хижняк С. Вплив натрій дихлорацетату на перебіг проокисно-антиоксидантних процесів в організмі мишей з саркомою 37 // Бiологiя. – 2011. – Випуск 57. – С. 35–37.
(check this in PDF content)
4
Сорокіна Л. В., Хижняк С. В., Дiденко Г. В., Степанова Л. I., Капля О. А. Структурний стан клітинних мембран саркоми 37 в динаміці росту // Фiзика живого. – 2010. – Т. 18. No 3. – С. 83–88.
(check this in PDF content)
5
Archer S. L., Weir E. K., Wilkins M. R. The basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies // Circulation. – 2010. – Vol. 121. No 18. – P. 2045–2066.
(check this in PDF content)
6
Barsan W. G. Treatment of cerebral ischemia with dichloroacetate // United States Patent Number: 4,631,294. – Date of Patent: Dec. 23, 1986. – Appl. No.: 752,091. – Filed: Jul. 5, 1985.
(check this in PDF content)
7
Bonnet S., Archer S. L., Allalunis-Turner J., Haromy A., Beaulieu C., Thompson R. et al. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth // Cancer Cell. – 2007. – Vol. 11. No 1. – P. 37–51.
(check this in PDF content)
8
Brandsma D., Dorlo T. P., Haanen J. H., Beijnen J. H., Boogerd W. Severe encephalopathy and polyneuropathy induced by dichloroacetate // Journal of Neurology. – 2010. – Vol. 257. No 12. – P. 2099–2100.
(check this in PDF content)
9
Cao W., Yacoub S., Shiverick K. T., Namiki K., Sakai Y., Porvasnik S. et al. Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation // The Prostate. – 2008. – Vol. 68. No 11. – P. 1223–1231.
(check this in PDF content)
10
Stefano N., Matthews P. M., Ford B. et al. Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders // Neurology. – 1995. – Vol. 45. No 6. – P. 1193–1198.
(check this in PDF content)
11
Dhar S., Lippard S. J. Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate // Proceedings of the National Academy of Sciences of the United States of America. – 2009. – Vol. 106. No 52. – P. 22199–22204.
(check this in PDF content)
12
Duncan G. E., Perkins L. A., Theriaque D. W., Neiberger R. E., Stacpoole P. W. Dichloroacetate therapy attenuates the blood lactate response to submaximal exercise in patients with defects in mitochondrial energy metabolism // The Journal of Clinical Endocrinology & Metabolism. – 2004. – Vol. 89. No 4. – P. 1733– 1738.
(check this in PDF content)
13
Fereidoonnezhad M., Faghih Z., Mojaddami A., Tabaei S. M. H., Rezaei Z. Novel approach synthesis, molecular docking and cytotoxic activity evaluation of N-phenyl-2,2-dichloroacetamide derivatives as anticancer agents // Journal of Sciences, Islamic Republic of Iran. – 2016. – Vol. 27. No 1. – P. 39–49.
(check this in PDF content)
14
Fiebiger W., Olszewski U., Ulsperger E., Geissler K., Hamilton G. In vitro cytotoxicity of novel platinum-based drugs and dichloroacetate against lung carcinoid cell lines // Clinical & translational oncology. – 2011. – Vol. 13. No 1. – P. 43–49.
(check this in PDF content)
15
Flavin D. Medullary thyroid carcinoma relapse reversed with dichloroacetate: a case report // Oncology Letters. – 2010. – Vol. 1. No 5. – P. 889–891.
(check this in PDF content)
16
Heshe D., Hoogestraat S., Brauckmann C., Karst U., Boos J., Lanvers-Kaminsky C. Dichloroacetate metabolically targeted therapy defeats cytotoxicity of standard anticancer drugs // Cancer Chemotherapy and Pharmacology. – 2011. – Vol. 67. No 3. – P. 647–655.
(check this in PDF content)
17
Ishiguro T., Ishiguro R., Ishiguro M., Iwai S. Co-treatment of dichloroacetate and omeprazole dramatically reduced the pain of pancreatic and bile duct cancer; possible blockade of their invasion // Abdominal Oncology. – 2013. – Vol. 1. – P. 1–4.
(check this in PDF content)
18
Ishiguro T., Ishiguro R., Ishiguro M., Iwai S. Co-treatment of dichloroacetate, omeprazole and tamoxifen exhibited synergistically antiproliferative effect on malignant tumors: in vivo experiments and a case report // Hepatogastroenterology. – 2012. – Vol. 59. No 116. – P. 994–996.
(check this in PDF content)
19
Jung G. -S., Jeon J. -H., Choi Y. -K., Jang S. Y., Park S. Y., Kim S. -W., Byun J. -K., Kim M. -K., Lee S., Shin E. -C., Lee I. -K., Kang Y. N., Park K. -G. Pyruvate dehydrogenase kinase regulates hepatitis C virus replication // Scientific Reports. – 2016. – Vol. 6. – Article number 30846.
(check this in PDF content)
20
Kaufmann P., Engelstad K., Wei Y., Jhung S., Sano M. C., Shungu D. C. et al. Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial // Neurology. – 2006. – Vol. 66. No 3. – P. 324–330.
(check this in PDF content)
21
Khan A. Case report of long term complete remission of metastatic renal squamous cell carcinoma after palliative radiotherapy and adjuvant dichloroacetate // Advances in Cancer: Research & Treatment. – 2012. – Vol. 2012. – Article ID 441895.
(check this in PDF content)
22
Khan A. Use of oral dichloroacetate for palliation of leg pain arising from metastatic poorly differentiated carcinoma: a case report // Journal of Palliative Medicine. – 2011. – Vol. 14. No 8. – P. 973–977.
(check this in PDF content)
23
Kinnaird A., Dromparis P., Haromy A., Bowers L., Hashimoto K., Sutendra G. et al. Dichloroacetate is a novel therapy for renal cell carcinoma // The Journal of Urology. – 2012. – Vol. 187. No 4. – P. e120–e121.
(check this in PDF content)
24
Kinnaird A., Dromparis P., Saleme B., Gurtu V., Watson K., Paulin R., Zervopoulos S., Stenson T., Sutendra G., Pink D. B., Carmine-Simmen K., Moore R., Lewis J. D., Michelakis E. D. Metabolic modulation of clear-cell renal cell carcinoma with dichloroacetate, an inhibitor of pyruvate dehydrogenase kinase // European Urology. – 2016. – Vol. 69. No 4. – P. 734–744.
(check this in PDF content)
25
Kluza J., Corazao-Rozas P., Touil Y., Jendoubi M., Maire C., Guerreschi P. et al. Inactivation of the HIF-1alpha/ PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants // Cancer Research. – 2012. – Vol. 72. No 19. – P. 5035–5047.
(check this in PDF content)
26
Kwitniewski M., Moan J., Juzeniene A. Metabolic-targeted therapy with dichloroacetate (DCA): a novel treatment strategy to improve the outcome of photodynamic therapy // Photochemical & Photobiological Sciences. – 2011. – Vol. 10. No 1. – P. 25–28.
(check this in PDF content)
27
Li T., Schultz I., Keys D. A., Campbell J. L., Fisher J. W. Quantitative evaluation of dichloroacetic acid kinetics in human – a physiologically based pharmacokinetic modeling investigation // Toxicology. – 2008. – Vol. 245. No 1–2. – P. 35–48.
(check this in PDF content)
28
Ludvik B., Peer G., Berzlanovich A., Stifter S., Graf H. Effects of dichloroacetate and bicarbonate on haemodynamic parameters in healthy volunteers // Clinical Science. – 1991. – Vol. 80. No 1. – P. 47–51.
(check this in PDF content)
29
Madhok B. M., Yeluri S., Perry S. L., Hughes T. A., Jayne D. G. Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells // British Journal of Cancer. – 2010. – Vol. 102. No 12. – P. 1746–1752.
(check this in PDF content)
30
Michelakis E. D., Sutendra G., Dromparis P., Webster L., Haromy A., Niven E. et al. Metabolic modulation of glioblastoma with dichloroacetate // Science Translational Medicine. – 2010. – Vol. 2. No 31. – P. 31ra34.
(check this in PDF content)
31
Michelakis E. D., Webster L., Mackey J. R. Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer // British Journal of Cancer. – 2008. – Vol. 99. No 7. – P. 989–994.
(check this in PDF content)
32
Ohashi T., Akazawa T., Aoki M., Kuze B., Mizuta K., Ito Y., Inoue N. Dichloroacetate improves immune dysfunction caused by tumor-secreted lactic acid and increases antitumor immunoreactivity // International Journal of Cancer. – 2013. – Vol. 133. No 5. – P. 1107–1118.
(check this in PDF content)
33
Olszewski U., Poulsen T. T., Ulsperger E., Poulsen H. S., Geissler K., Hamilton G. In vitro cytotoxicity of combinations of dichloroacetate with anticancer platinum compounds // Clinical Pharmacology: Advances and Applications. – 2010. – Vol. 2. – P. 177–183.
(check this in PDF content)
34
Pfeffer G., Majamaa K., Turnbull D. M. et al. Treatment for mitochondrial disorders // Cochrane Database of Systematic Reviews. – 2012. – No 4. – CD004426.
(check this in PDF content)
35
Rajendran A., Bansal D., Marwaha R. K., Singhi S. C. Tumor lysis syndrome // The Indian Journal of Pediatrics. – 2013. – Vol. 80. No 1. – P. 50–54.
(check this in PDF content)
36
Ribes G., Valette G., Loubatieres-Mariani M. -M. Metabolic effects of sodium dichloroacetate in normal and diabetic dogs // Diabetes. – 1979. – Vol. 28. No 9. – P. 852–857.
(check this in PDF content)
37
Roh J. - L., Park J. Y., Kim E. H., Jang H. J., Kwon M. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer // Cancer Letters. – 2016. – Vol. 371. No 1. – P. 20–29.
(check this in PDF content)
38
Rozier M. D., Zata V. J., Ellsworth M. L. Lactate interferes with ATP release from red blood cells // The American Journal of Physiology. Heart and Circulatory Physiology. – 2007. – Vol. 292. No 6. – P. H3038-H3042.
(check this in PDF content)
39
Saed G. M., Fletcher N. M., Jiang Z. L., Abu-Soud H. M., Diamond M. P. Dichloroacetate induces apoptosis of epithelial ovarian cancer cells through a mechanism involving modulation of oxidative stress // Reproductive Sciences. – 2011. – Vol. 18. No 12. – P. 1253–1261.
(check this in PDF content)
40
Shahrzad S., Lacombe K., Adamcic U., Minhas K., Coomber B. L. Sodium dichloroacetate (DCA) reduces apoptosis in colorectal tumor hypoxia // Cancer Letters. – 2010. – Vol. 297. No 1. – P. 75–83.
(check this in PDF content)
41
Shen H., Decollogne S., Dilda P. J., Hau E., Chung S. A., Luk P. P., Hogg P. J., McDonald K. L. Dual-targeting of aberrant glucose metabolism in glioblastoma // Journal of Experimental & Clinical Cancer Research. – 2015. – Vol. 34. No 1. – Article 14.
(check this in PDF content)
42
Shen Y., Fan H., Ou D., Liao S., Cheng A. et al. Dichloroacetate (DCA) enhances activities of sorafenib against hepatocellular carcinoma (HCC) via modulation of aberrant cellular metabolism of HCC cells // Molecular Cancer Therapeutics. – 2009. – Vol. 8. No 12 (Suppl.). – Abstract B97.
(check this in PDF content)
43
Shen Y. C., Ou D. L., Hsu C., Lin K. L., Chang C. Y., Lin C. Y. et al. Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma // British Journal of Cancer. – 2013. – Vol. 108. No 1. – P. 72–81.
(check this in PDF content)
44
Stacpoole P. W. Review of the pharmacologic and therapeutic effects of diisopropylammonium dichloroacetate (DIPA) // The Journal of Clinical Pharmacology. – 1969. – Vol. 9. No 5. – P. 282–291.
(check this in PDF content)
45
Stacpoole P. W. The pharmacology of dichloroacetate // Metabolism – Clinical and Experimental. – 1989. – Vol. 38. No 11. – P. 1124–1144.
(check this in PDF content)
46
Stacpoole P. W. Treatment of hyperlipoproteinemia with a dichloroacetate salt // United States Patent Number: 4,122,188. – Date of Patent: Oct. 24, 1978. – Appl. No: 828, 677. – Filed: Aug. 29, 1977.
(check this in PDF content)
47
Stacpoole P. W., Dunbar E. M., Shroads A. L., Coats B. S., Langaee T. Predictability of glutathione transferase zeta 1 haplotype on kinetics of dichloroacetate in human trials // Drug Metabolism Reviews. – 2011. – Vol. 43. – Suppl. 2. – P. 181–182.
(check this in PDF content)
48
Stacpoole P. W., Henderson G. N., Yan Z., Cornett R., James M. O. Pharmacokinetics, metabolism and toxicology of dichloroacetate // Drug Metabolism Reviews. – 1998. – Vol. 30. No 3. – P. 499–539.
(check this in PDF content)
49
Stacpoole P. W., Kerr D. S., Barnes C., Bunch S. T., Carney P. R., Fennell E. M. et al. Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children // Pediatrics. – 2006. – Vol. 117. No 5. – P. 1519–1531.
(check this in PDF content)
50
Stacpoole P. W., Nagaraja N. V., Hutson A. D. Efficacy of dichloroacetate as a lactate-lowering drug // Journal of Clinical Pharmacology. – 2003. – Vol. 43. No 7. – P. 683–691.
(check this in PDF content)
51
Strum S. B., Adalsteinsson O., Black R. R., Segal D., Peress N. L., Waldenfels J. Case report: sodium dichloroacetate (DCA) inhibition of the "Warburg effect" in a human cancer patient: complete response in non-Hodgkin's lymphoma after disease progression with rituximab-CHOP // Journal of Bioenergetics and Biomembranes. – 2013. – Vol. 45. No 3. – P. 307–315.
(check this in PDF content)
52
Sun R. C., Board P. G., Blackburn A. C. Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells // Molecular Cancer. – 2011. – Vol. 10. – Article 142.
(check this in PDF content)
53
Sun R. C., Fadia M., Dahlstrom J. E., Parish C. R., Board P. G., Blackburn A. C. Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo // Breast Cancer Research and Treatment. – 2010. – Vol. 120. No 1. – P. 253–260.
(check this in PDF content)
54
Tong J., Xie G., He J., Li J., Pan F., Liang H. Synergistic antitumor effect of dichloroacetate in combination with 5-fluorouracil in colorectal cancer // Journal of Biomedicine & Biotechnology. – 2011. – Vol. 2011. – Article ID 740564.
(check this in PDF content)
55
Valauri-Orton A., Bschorer F., Bernd K. K. Dichloroacetate decreases cell health and activates oxidative stress defense pathways in rat alveolar type II pneumocytes // BioMed Research International. – 2015. – Vol. 2015. – Article ID 129031.
(check this in PDF content)
56
Vella S., Conti M., Tasso R., Cancedda R., Pagano A. Dichloroacetate inhibits neuroblastoma growth by specifically acting against malignant undifferentiated cells // International Journal of Cancer. – 2012. – Vol. 130. No 7. – P. 1484–1493.
(check this in PDF content)
57
Vissing J., Gansted U., Quistorff B. Exercise intolerance in mitochondrial myopathy is not related to lactic acidosis // Annals of Neurology. – 2001. – Vol. 49. No 5. – P. 672–676.
(check this in PDF content)
58
Wargovich T. J., MacDonald R. G., Hill J. A., Feldman R. L., Stacpoole P. W., Pepine C. J. Myocardial metabolic and hemodynamic effects of dichloroacetate in coronary artery disease // The American Journal of Cardiology. – 1988. – Vol. 61. No 1. – P. 65–70.
(check this in PDF content)
59
Washington J. T., Quintyne N. J. Dichloroacetate induces different rates of cell death in cancer and noncancer cell lines in vitro // Tumori. – 2012. – Vol. 98. No 1. – P. 142–151.
(check this in PDF content)
60
Wong J. Y., Huggins G. S., Debidda M., Munshi N. C., De Vivo I. Dichloroacetate induces apoptosis in endometrial cancer cells // Gynecologic Oncology. – 2008. – Vol. 109. No 3. – P. 394–402.
(check this in PDF content)
61
Xiao H., Yan L., Zhang Y., Qi R., Li W., Wang R. et al. A dual-targeting hybrid platinum (IV) prodrug for enhancing efficacy // Chemical Communications. – 2012. – Vol. 48. No 87. – P. 10730– 10732.
(check this in PDF content)
62
Xiao L., Li X., Niu N., Qian J., Xie G., Wang Y. Dichloroacetate (DCA) enhances tumor cell death in combination with oncolytic adenovirus armed with MDA-7/IL-24 // Molecular and Cellular Biochemistry. – 2010. – Vol. 340. No 1. – P. 31–40.
(check this in PDF content)
63
Xie J., Wang B. S., Yu D. H., Lu Q., Ma J., Qi H. et al. Dichloroacetate shifts the metabolism from glycolysis to glucose oxidation and exhibits synergistic growth inhibition with cisplatin in HeLa cells // International Journal of Oncology. – 2011. – Vol. 38. No 2. – P. 409–417.
(check this in PDF content)
64
Xue X., You S., Zhang Q., Wu Y., Zou G. Z., Wang P. C. et al. Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction // Molecular Pharmaceutics. – 2012. – Vol. 9. No 3. – P. 634–644.
(check this in PDF content)
65
Zajac J., Kostrhunova H., Novohradsky V., Vrana O., Raveendran R., Gibson D., Kasparkova J., Brabec V. Potentiation of mitochondrial dysfunction in tumor cells by conjugates of metabolic modulator dichloroacetate with a Pt(IV) derivative of oxaliplatin // Journal of Inorganic Biochemistry. – 2016. – Vol. 156. – P. 89–97.
(check this in PDF content)
66
Zhang N., Palmer A. F. Development of a dichloroacetic acid-hemoglobin conjugate as a potential targeted anti-cancer therapeutic // Biotechnology and Bioengineering. – 2011. – Vol. 108. No 6. – P. 1413–1420. Поступила 30.12.16
(check this in PDF content)